Torres GO, Galindo RK, Pozo CS, Cheong QM, Rodríguez RBN

Language: Spanish
References: 8
Page: 1-14
PDF size: 399.01 Kb.

ABSTRACT

Macular edema is the abnormal thickening of the macula associated to fluid accumulation in the extracellular space of the neurosensory retina. Some cases also present intracellular edema with involvement of Müller cells. One of these causes is macular edema after cataract surgery. A case is presented of a male 57-year-old patient of black skin color with a history of cataract surgery in both eyes. The left eye had no vision, due to rejection to the penetrating corneal transplantation performed. The right eye presented macular edema with intraocular lens subluxation. Examination included biomicroscopy of the anterior and posterior segments, optical coherence tomography, visual acuity with correction and intraocular pressure. A diagnosis was confirmed of macular edema with epiretinal membrane and intraocular lens subluxation. It was decided to fix the lens to the sclera using the Yamane technique, since it was a three-piece lens with a C-shaped polyvinylidene fluoride haptic (CT Lucia 602 from Zeiss), ideal for this technique. An Ozurdex dose was administered in the right eye to treat the macular edema, since topical anti-inflammatory eyedrops were not effective in this case, and improvement of the edema was achieved for about three months. In postoperative macular edema, it is not only necessary to treat the inflammation, but also its cause.

REFERENCES

1. Kapoor K, Wagner M, Wagner A. The sustained release dexamethasone implant: expanding indications in viteoretinal disease. Semin Ophthalmol. 2015;30(30):5-6. DOI: https://doi.org/10.3109/08820538.2014.889179

2. London N, Chiang A, Haller J. The dexamethasone drug delivery system: indications and evidence. Adv Ther. 2011;28(5):336-51. DOI: https://doi.org/10.1007/s12325-011-0019-z

3. Kuppermann BD, Goldstein M, Maturi RK, Pollack A, Singer M, Tufail A, et al. Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial. Ophthalmologica. 2015;234(1):40-54. DOI: https://doi.org/10.1159/000381865

4. Garweg JG, Zandi S. Retinal vein occlusion and the use of a dexamethasone intravitreal implant (OzurdexR) in its treatment. Graefe's Arch Clin Experim Ophthalmol. 2016;254(7):1257-65. DOI: https://doi.org/10.1007/s00417-016-3350-x

5. Rocke JR, Mcguinness MB, Atkins WK, Fry LE, Kane JX, Fabinyi DC, et al. Refractive Outcomes of the Yamane Flanged Intrascleral Haptic Fixation Technique. Ophthalmology. 2020:127(10). DOI: https://doi.org/10.1016/j.ophtha.2020.03.032

6. Adan A, Pelegrin L, Rey A, Llorenc V, Mesquida M, Molins B, et al. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Retina. 2013:33(7):1435-40. DOI: https://doi.org/10.1097/IAE.0b013e31827e247b

7. Esen E, Sizmaz S, Demircan N. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema. Int Ophthalmol. 2017;37(1):1-6. DOI: https://doi.org/10.1007/s10792-016-0219-2

8. Abdala C, Acosta Reyes J, Arrascue S, Unigarro J, Vidal S, Rueda J. Experiencia del implante de dexametasona intravítreo para el tratamiento del edema macular en Barranquilla, Colombia. Rev Soc Col Oftalmol. 2017 [acceso: 30/11/2018];50(2):86-93. Disponible en: https://docs.bvsalud.org/biblioref/2018/06/885036/experiencia-del-implante.pdf